Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnevist in Children 2 Months to < 2 Years Undergoing MRI
NCT00937391Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of gadopentetate dimeglumine in Not a disease, sponsored by Bayer. Started Jan 2010; status: completed.
02
Drugs
gadopentetate dimeglumine
03
Conditions
Not a disease
Beyond the preview
Go deeper on NCT00937391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937391.